vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.

SPS COMMERCE INC is the larger business by last-quarter revenue ($192.7M vs $121.8M, roughly 1.6× Core Laboratories Inc.). SPS COMMERCE INC runs the higher net margin — 13.4% vs 4.2%, a 9.2% gap on every dollar of revenue. On growth, SPS COMMERCE INC posted the faster year-over-year revenue change (12.7% vs -1.4%). SPS COMMERCE INC produced more free cash flow last quarter ($38.2M vs $517.0K). Over the past eight quarters, SPS COMMERCE INC's revenue compounded faster (13.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

CLB vs SPSC — Head-to-Head

Bigger by revenue
SPSC
SPSC
1.6× larger
SPSC
$192.7M
$121.8M
CLB
Growing faster (revenue YoY)
SPSC
SPSC
+14.2% gap
SPSC
12.7%
-1.4%
CLB
Higher net margin
SPSC
SPSC
9.2% more per $
SPSC
13.4%
4.2%
CLB
More free cash flow
SPSC
SPSC
$37.7M more FCF
SPSC
$38.2M
$517.0K
CLB
Faster 2-yr revenue CAGR
SPSC
SPSC
Annualised
SPSC
13.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
SPSC
SPSC
Revenue
$121.8M
$192.7M
Net Profit
$5.1M
$25.8M
Gross Margin
70.4%
Operating Margin
1.5%
18.0%
Net Margin
4.2%
13.4%
Revenue YoY
-1.4%
12.7%
Net Profit YoY
47.2%
EPS (diluted)
$0.11
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
SPSC
SPSC
Q1 26
$121.8M
Q4 25
$138.3M
$192.7M
Q3 25
$134.5M
$189.9M
Q2 25
$130.2M
$187.4M
Q1 25
$123.6M
$181.5M
Q4 24
$129.2M
$170.9M
Q3 24
$134.4M
$163.7M
Q2 24
$130.6M
$153.6M
Net Profit
CLB
CLB
SPSC
SPSC
Q1 26
$5.1M
Q4 25
$4.9M
$25.8M
Q3 25
$14.2M
$25.6M
Q2 25
$10.6M
$19.7M
Q1 25
$-154.0K
$22.2M
Q4 24
$7.4M
$17.6M
Q3 24
$11.7M
$23.5M
Q2 24
$9.0M
$18.0M
Gross Margin
CLB
CLB
SPSC
SPSC
Q1 26
Q4 25
20.8%
70.4%
Q3 25
22.0%
69.5%
Q2 25
20.3%
68.1%
Q1 25
19.5%
68.7%
Q4 24
17.8%
67.5%
Q3 24
20.5%
68.5%
Q2 24
21.2%
66.1%
Operating Margin
CLB
CLB
SPSC
SPSC
Q1 26
1.5%
Q4 25
11.5%
18.0%
Q3 25
15.6%
16.4%
Q2 25
11.7%
14.1%
Q1 25
3.6%
14.3%
Q4 24
11.0%
14.5%
Q3 24
14.7%
15.6%
Q2 24
12.3%
15.1%
Net Margin
CLB
CLB
SPSC
SPSC
Q1 26
4.2%
Q4 25
3.6%
13.4%
Q3 25
10.6%
13.5%
Q2 25
8.2%
10.5%
Q1 25
-0.1%
12.2%
Q4 24
5.7%
10.3%
Q3 24
8.7%
14.3%
Q2 24
6.9%
11.7%
EPS (diluted)
CLB
CLB
SPSC
SPSC
Q1 26
$0.11
Q4 25
$0.11
$0.69
Q3 25
$0.30
$0.67
Q2 25
$0.22
$0.52
Q1 25
$0.00
$0.58
Q4 24
$0.15
$0.46
Q3 24
$0.25
$0.62
Q2 24
$0.19
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
SPSC
SPSC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$151.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$973.9M
Total Assets
$587.7M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
SPSC
SPSC
Q1 26
$22.8M
Q4 25
$22.7M
$151.4M
Q3 25
$25.6M
$133.7M
Q2 25
$31.2M
$107.6M
Q1 25
$22.1M
$94.9M
Q4 24
$19.2M
$241.0M
Q3 24
$21.5M
$205.8M
Q2 24
$17.7M
$271.8M
Total Debt
CLB
CLB
SPSC
SPSC
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
SPSC
SPSC
Q1 26
$275.1M
Q4 25
$266.0M
$973.9M
Q3 25
$271.3M
$958.9M
Q2 25
$261.3M
$949.8M
Q1 25
$253.4M
$920.9M
Q4 24
$246.6M
$854.7M
Q3 24
$250.7M
$829.4M
Q2 24
$240.3M
$703.4M
Total Assets
CLB
CLB
SPSC
SPSC
Q1 26
$587.7M
Q4 25
$584.0M
$1.2B
Q3 25
$591.4M
$1.2B
Q2 25
$602.1M
$1.1B
Q1 25
$591.5M
$1.1B
Q4 24
$585.1M
$1.0B
Q3 24
$600.5M
$1.0B
Q2 24
$597.8M
$854.5M
Debt / Equity
CLB
CLB
SPSC
SPSC
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
SPSC
SPSC
Operating Cash FlowLast quarter
$4.0M
$45.9M
Free Cash FlowOCF − Capex
$517.0K
$38.2M
FCF MarginFCF / Revenue
0.4%
19.8%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
0.77×
1.78×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$152.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
SPSC
SPSC
Q1 26
$4.0M
Q4 25
$7.9M
$45.9M
Q3 25
$8.5M
$60.6M
Q2 25
$13.9M
$32.3M
Q1 25
$6.7M
$40.0M
Q4 24
$20.6M
$40.6M
Q3 24
$13.1M
$53.3M
Q2 24
$17.1M
$29.4M
Free Cash Flow
CLB
CLB
SPSC
SPSC
Q1 26
$517.0K
Q4 25
$5.0M
$38.2M
Q3 25
$6.5M
$54.6M
Q2 25
$10.4M
$25.7M
Q1 25
$3.9M
$33.8M
Q4 24
$17.4M
$34.3M
Q3 24
$10.4M
$48.1M
Q2 24
$14.3M
$24.4M
FCF Margin
CLB
CLB
SPSC
SPSC
Q1 26
0.4%
Q4 25
3.6%
19.8%
Q3 25
4.8%
28.7%
Q2 25
8.0%
13.7%
Q1 25
3.1%
18.6%
Q4 24
13.4%
20.1%
Q3 24
7.7%
29.4%
Q2 24
10.9%
15.9%
Capex Intensity
CLB
CLB
SPSC
SPSC
Q1 26
Q4 25
2.1%
4.0%
Q3 25
1.5%
3.2%
Q2 25
2.7%
3.6%
Q1 25
2.3%
3.4%
Q4 24
2.5%
3.6%
Q3 24
2.0%
3.2%
Q2 24
2.2%
3.3%
Cash Conversion
CLB
CLB
SPSC
SPSC
Q1 26
0.77×
Q4 25
1.61×
1.78×
Q3 25
0.60×
2.37×
Q2 25
1.31×
1.64×
Q1 25
1.80×
Q4 24
2.78×
2.31×
Q3 24
1.12×
2.27×
Q2 24
1.90×
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

Related Comparisons